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The sarcomeric Z-disc deﬁnes the lateral borders of the sarcomere and has primarily been seen as a structure important for
mechanical stability. This view has changed dramatically within the last one or two decades. A multitude of novel Z-disc
proteins and their interacting partners have been identiﬁed, which has led to the identiﬁcation of additional functions and
which have now been assigned to this structure. This includes its importance for intracellular signalling, for mechanosensation
and mechanotransduction in particular, an emerging importance for protein turnover and autophagy, as well as its molecular
links to the t-tubular system and the sarcoplasmic reticulum. Moreover, the discovery of mutations in a wide variety of Z-disc
proteins, which lead to perturbations of several of the above-mentioned systems, gives rise to a diverse group of diseases which
can be termed Z-discopathies. This paper provides a brief overview of these novel aspects as well as points to future research
directions.
1.Introduction
Z-discs (Z-disk, Z-line, Z-band) delineate the lateral borders
ofsarcomeresandarethesmallest functional unitsinstriated
muscle. The core of a Z-disc consists of actin ﬁlaments com-
ing from adjacent sarcomeres which are crosslinked by α
actinin molecules [1]. Mature Z-discs are probably com-
posed of hundreds of diﬀerent proteins, and one regards
them as one of the most complex macromolecular structures
in biology [2]. Z-discs, which are diﬃcult to detect in
conventional light microscopy, appear in the longitudinal
view of electron microscopy as electron dense bands with
varying sizes, ranging between 30 and 50nm in fast muscle
and between 100 and 140nm in slow muscle and cardiac
myocytes. In the transverse view, they appear as a “bas-
ketweave” or as “small square lattices” [3]. F-actin ﬁlaments,
titin, and the nebulin/nebulette system directly attach to
the Z-disc, and, because of their importance for sarcomere
mechanics, the Z-disc has initially been regarded as impor-
tant for mechanical stability only.
However, within the last decade, our knowledge with re-
gard to this structure increased steadily, and it is now
clear that the sarcomeric Z-disc serves as a nodal point for
signalling in general and mechanosensation and mechan-
otransduction in particular. The Z-disc also links to the
t-tubular system, the sarcoplasmic reticulum, and several
E3 ubiquitin ligases localized to the Z-disc and link this
structure to protein turnover and probably autophagy.
While excellent reviews with regard to the structural
aspects of the Z-disc [4, 5] and with emphasis on its role in
signalling [6–9] have been published recently, we will focus
more on the role of the Z-disc in disease and will highlight
recent developmentsin the exciting ﬁeld of Z-disc biology.
Although we use the term “Z-disc protein” in this paper,
such a protein is diﬃcult to deﬁne. This is because (i) a pro-
t e i na tt h eZ - d i s cm a yn o ta l w a y sb ec o n ﬁ n e dt ot h ed i s c —
depending on developmental stage and physiological cir-
cumstances; (ii)itmay befound atother locations within the
sarcomere, such as the I- and M-bands (i.e., FHL1 and 2);
(iii) these proteins can also be in multiple localizations,
including the nucleus (such as muscle LIM protein, (MLP)),
costamere (such as integrin linkedkinase, (ILK)),cytoplasm,
intercalated disc, sarcoplasmic reticulum, and t-tubules. An-
other example is desmin, which is present at the sarcomeric
Z-disc but as an intermediate ﬁlament (IF); it connects
not only this structure with the desmosomes but has other2 Journal of Biomedicine and Biotechnology
links to other compartments, linking these to the nucleus
a sw e l l .O t h e re x a m p l e so fZ - d i s cp r o t e i n si n c l u d et h eg i a n t
protein titin, where only the amino-terminus is located to
the Z-disc, and nebulin/nebulette, where only the carboxy-
terminus is localized to the Z-disc and/or F-actin. In this
context, an NCBI online search (http://www.ncbi.nlm.nih
.gov/guide/) revealed that currently about 227 gene products
or proteins are associated with the Z disc, and at least
about 50 human and about 60 mouse gene products have
been assigned to it. Due to space restrictions, this paper
cannot discuss all of these proteins, but will focus on some
signiﬁcant recent developments and point out some impor-
tant and particularly disease-associated proteins and their
genes.
2.StructuralAspects
Z-discs can be deﬁned as plate-like structures in sarcomeres
towhich theplusendsofactin ﬁlamentsarelocalized,orthey
can be deﬁned as the centre of the I-band. As pointed out
above, they are probably composed of hundreds of diﬀerent
proteins and are regarded as one of the most complex
macromolecular structures in biology [2]. Major Z-disc pro-
teins include cardiac actin which is crosslinked by α actinin
and “capped” by CapZ, titin, which spans a complete half
sarcomere, and nebulin/nebulette which runs along actin
ﬁlaments.
Z-discs, which are diﬃcult to detect in conventional light
microscopy, appear in the longitudinal view of electron mi-
croscopy as dense zigzag bands with varying but myoﬁbre-
speciﬁc sizes, ranging between 30 to 50nm in fast muscle
and between 100 to 140nm in slow muscle and cardiac
myocytes. Z-disc widths are determined by the layers of α
actinin, which can range from two to six or even more
molecules [10, 11]. It is interesting to ﬁnd the thinnest
Z-discs in the fastest muscle ﬁbres, which, functionally,
produce the highest sarcomere-shortening velocities, and
the widest Z-discs in slow muscle. It is diﬃcult to give
an explanation for this phenomenon, but, if the Z disc
contributes to series elasticity, perhaps via its connection to
titin, thinner discs may provide less elasticity (=stiﬀer cell).
As the contractile apparatus is activated, it has to stretch
the discs in series before force transmits—so cellular force
transmission throughout the muscle would have a shorter
delay and be faster. Also, may be via z-disc/titin/actomyosin
interaction crossbridge that cycling may be faster. In the
transverse view, Z-discs appear as “basketweaves” or “small
square lattices” [3], and it has been proposed by Goldstein
and coworkers [12–14] as well as by Yamaguchi et al. [15],
that the Z-disc changes its structure, from small square
lattice in resting muscle to a wider basketweave form in
activated muscle [13]. A study of α actinin binding to actin
within the Z-disc revealed that the angles between both
proteins varied preferentially between 60 and 120 degrees
[16]. Both the conformational change of the Z-disc during
contraction as well as the changes of the angles between
α actinin and actin could well be part of a stress-sensing
mechanism.
3.Z-Disc-Related Proteins
3.1. α Actinin. α actinin belongs to the spectrin gene super-
family which includes a wide variety of diﬀerent cytoskeletal
components including dystrophin, utrophin, ﬁmbrin, and
alpha and beta spectrins. The skeletal and cardiac muscle
isoforms are localized to the sarcomeric Z-discs and are
important for actin localization. Various splice variants have
been reported, thelargestofwhich contains892amino acids.
The matureproteinis about35nminlengthandoccursasan
antiparallel homodimer. The single protein consists of four
spectrin repeats at its centre as well as of an actin-binding
domain (ABD) at its amino-terminus and two EF hands
(calmodulin homology domains) at the carboxy-terminus,
which enableα actinin to crosslink actin ﬁlaments within the
Z-disc. A single mutation in α actinin (Q9R) has been found
in an individual aﬀected by DCM [17], and via linkage anal-
ysis the gene for α actinin (ACTN2) has been linked recently
to HCM[18, 19] (please see also Table 1 and Figure 1).The α
actinin Q9R mutation in particular disrupts the interaction
with MLP and seems to aﬀect cellular diﬀerentiation.
3.2. Muscle LIM Protein (MLP). Muscle LIM protein (for
Lin11, Isl 1, and Mec 3 (LIM)) is a 194 amino acid LIM-only
protein localized not only to the sarcomeric Z-disc, where it
interacts most probablywith αactinin [20], calcineurin[21],
and telethonin [22, 23], but is also present in the nucleus
where this protein is able to interact with myoD, myogenin,
and MRF4 [24], as well as at the intercalated discs where it
interacts with NRAP [25], and at the costameres where it
interacts with zyxin [20], integrin linked kinase (ILK) [26],
and β1s p e c t r i n[ 27]. MLP-deﬁcient animals developa severe
form of heart failure, and patients with mutations in this
gene develop forms of cardiomyopathy—either dilated car-
diomyopathy DCM (dilated, enlarged ventricular chambers
and inadequatesystolic function) orhypertrophic cardiomy-
opathy HCM (increase in myocardial wall thicknesses which
may or may not be associated with fatal arrhythmias) [28,
29]. MLP interacts with a variety of additional proteins such
as coﬁlin 2 [30]a n da c t i n[ 31] and is involved in actin poly-
merization. Moreover, the protein has been implicated in
varioussignaltransductioncascades,includingmechanosen-
sation and mechanotransduction, calcium metabolism, and
myoﬁbrillogenesis. Of note, MLP has also been reported
to be deacetylated by histone deacetylase 4 (HDAC4) and
acetylated by the histone acetylase (HAT) PCAM and that
its acetylation is linked to an increase myoﬁbrillar calcium
sensitivity [32]. Although little is known about the role of
HDACs and HATs with regard to their eﬀects on calcium
sensitivity, a possible link between these molecules, the Z-
disc, and contractility is of great interest because a direct link
between the Z-disc and calcium sensitivity has never been
shown before.However,futureresearch will havetoelucidate
thislinkinmuchmoredetail(forarecentreviewonMLP,see
[33]).
3.3.Telethonin(TCAP). Telethonin(titincap,t-cap,TCAP)is
a small 167 amino acid protein (molecular weight ∼19kDa)Journal of Biomedicine and Biotechnology 3
Table 1: Z-disc proteins involved in humandisease.
Name of gene Type of disease
α actinin (central Z-disc) Cardiomyopathy
Muscle LIM protein (MLP) Cardiomyopathy
Telethonin (TCAP) Cardiomyopathy, LGMD2G
Actin Cardiomyopathy
Integrin-linked kinase (ILK) DCM
Calsarcin1 (Myozenin, ZASP) Cardiomyopathy, myoﬁbrillar myopathy (MFM) zaspopathies
FHL1 (four and a half LIM domain protein) X-linked myopathy with postural muscle atrophy (XMPMA), scapuloperoneal
(SP),reducing body myopathy (RBM)
Cypher (Zasp, Oracle) Cardiomyopathy, MFM
Desmin (Z-disc related) Multiple
Nebulin/Nebulette Nemaline myopathy
Myotilin LGMD, MFM, myotilinopathy
BAG3 Cardiomyopathy, MFM
Titin (Z-disc)∗ Cardiomyopathy (titinopathies)
Z-disc protein mutations cause a wide spectrum of diseases, which may be called “Z-discopathies”. Titin mutation itself cause a broad spectrum of diseases
(here we refer only to mutations aﬀecting the Z-disc). The term cardiomyopathy includes at least HCM and DCM, other types of heart failure such as
arrhythmogenic right ventricular myopathy.
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Figure 1: The sarcomeric Z-disc—multiple functions and links to maladaptation. The ﬁgure links various functions and structural aspects
to maladaptation and disease, such as mutations in Z-disc proteins which are linked to diﬀerent diseases. Defects in mechanosensation and
mechanotransduction are linked to Z-disc mediated autophagy and UPS which in turn are linked to skeletal and cardiac muscle disease.4 Journal of Biomedicine and Biotechnology
striated-muscle-speciﬁc protein with a unique β-sheet struc-
ture. This protein, with unknown homologue genes, binds
in an antiparallel (2:1) sandwich complex at the periphery
of the sarcomeric Z-disc to the titin Z1-Z2 domains and
essentially “glues” together the N-termini of two adjacent
titin molecules [2]. This interaction represents also the
strongest protein-protein interaction observed to date [34].
In this regard, it will be interesting to analyze telethonin’s
function during biomechanical stress. Telethonin is an in
vitro substrate of titin kinase, an interaction thought to be
critical during myoﬁbril growth [35], and the protein also
can be phosphorylated by protein kinase D (PKD) which
might link telethonin to the regulation of G-protein-coupled
receptor (GPCR) signalling [36].
Telethonin interactsalso witha widevariety ofadditional
and very diﬀerent proteins, such as ankyrin repeat protein
2, small ankyrin 1 (a transmembrane protein of the sar-
coplasmic reticulum) [37], minK, a potassium channel β-
subunit, as well as with sodium channels such as Nav1.5 [38,
39]. Interestingly, the interaction with mink indicates a link
between telethonin and the t-tubular system, a connection
also observed in a telethonin-deﬁcient zebraﬁsh model [40].
However, the precise interplay between telethonin and the t-
tubular system needs to be elucidated.
In addition, telethonin interacts with MDM2 and muscle
ring ﬁngers 1/2 (MuRF1/2) [41, 42]—E3 ubiquitin ligases
strongly impacting cardiac protein turnover. It remains to
be elucidated which telethonin domains are involved in the
interaction with MuRF 1/2 and whether mutations aﬀect the
degradation process oftelethonin. It might well be that some
telethonin mutations may lead to forms of proteinopathies,
which are characterized by aggresome formation, autophagy,
and apoptosis (see next chapter).
Moreover, telethonin may participate in the regulation of
myocardial hypertrophy by interacting with calsarcin-1 (also
known as FATZ-2 or myozenin-2) [43], which is a mediator
of calcineurin activity. Telethonin interacts with, as well as
regulates, the secretion of myostatin, an important negative
regulatorof musclegrowth[44],andinteractswithBMP10,a
positive regulator of hypertrophy [45]. Therefore, telethonin
is well suited to inﬂuence the delicate balance between at-
rophy and hypertrophy or myocardial remodelling [28].
However, this link needs to be analyzed in more detail. Tel-
ethonin may also aﬀect cell survival by interacting with the
proapoptotic protein Siva [46] and is involved in cardiac
mechanosensation [22].
Nonsense mutationsinthetelethoningeneare associated
with limb-girdle muscular dystrophy type 2G (LGMD 2G)
[47–49], heterozygous missense mutations, with dilated and
hypertrophicformsofcardiomyopathy[18,22,50],aswell as
with intestinal pseudoobstruction [39]. However, a recently
discovered telethonin mutation (R76C), found in an indi-
vidual aﬀected by intestinal pseudoobstruction, aﬀected the
Nav1.5 (SCN5A)channel when coexpressed inHEK293 cells
alteringsteady-state activationkinetics[39].Whether this ef-
fect can also be observed in the heart or whether other
telethonin mutations also aﬀect ion channels requires eluci-
dation.
Todateitisnotatall clearwhy andhow telethoninmuta-
tions cause these broad-spectrum diseases. Ion channels, E3
ubiquitin ligases, autophagy, and apoptosis could well play
a role. In this regard, telethonin deﬁciency in a genetically
altered mouse model is not associated with a spontaneous
cardiac phenotype but leads to severe maladaptation and
heart failure following biomechanical stress. Telethonin in-
teracts with the proapoptotic protein p53 and facilitates its
degradation via MDM2. Loss of telethonin in the presence
of biomechanical stress increases p53 as well as apoptotic cell
death [51]. This novel link might help to explain some of the
pathologiesobservedin patientsaﬀectedbymutationsinthis
gene.
3.4. Integrin-Linked kinase (ILK). ILK has been identiﬁed
as an integrin-binding protein and has also been localized
to the sarcomeric Z-disc, but the functionality of its kinase
domain in vivo has recently been questioned [52]. The
ternary complex of ILK, Pinch and Parvin (IPP) interacts
with the cytoplasmic tail of β integrin and couples them
to the actin cytoskeleton. ILK is found at costameres and
has also been localized to the Z-disc area where this protein
interacts with a host of diﬀerent proteins, including MLP
[26]o rc - S r c[ 53]. It has also been implicated in Akt-
mediated survival signalling. An ILK nonsense mutation has
been identiﬁed in zebraﬁsh which leads to a “lost contact”
phenotype indicating that cells, particularly endothelial cells
and cardiac myocytes, lose contact with their surrounding
cells. In addition, a human ILK mutation (A262V) has
been described in a DCM patient. This mutation, when
injected into an ILK-deﬁcient zebraﬁsh, did not rescue the
phenotype, while wildtype ILK does. Among other eﬀects,
ILK A262V was also associated with a decrease in capillary
density in human myocardial tissue. By aﬀecting both,
cardiac myocytes and endothelial cells, ILK A262V causes
cardiomyopathy and associated heart failure via a novel
molecular mechanism [54].
3.5. Melusin. Melusin is a muscle-speciﬁc protein located at
costameres near the Z-disc, where it binds to the cytoplasmic
domain of β1i n t e g r i n[ 55]. Homozygous deletion of this
gene is not associated with a spontaneous phenotype,
but leads to a reduced left ventricular hypertrophy and a
transition to DCM following transverse aortic constriction
(TAC). More interestingly, deﬁciency of this protein is not
associated with any loss of sensitivity to humoral factors
such as angiotensin II or phenylephrine in terms of a
myocardial hypertrophic response. Further analysis revealed
that following pressure overload glycogen synthase kinase 3β
(GSK 3β) and Akt phosphorylation were blunted in melusin
deﬁcient hearts [56]. Conversely, melusin overexpression is
protective after TAC [57]. In addition, a search for melusin
mutations in human heart failure patients revealed the
presence of three diﬀerent genetic variations, but a clear
genotype-phenotype relationship could not be established
[58].
Thus, melusin is an element of the integrin-dependent
cardiac mechanosensor machinery, it may be indispensableJournal of Biomedicine and Biotechnology 5
for adaptive cardiac remodelling, and melusin might serve as
a therapeutic target in heart failure.
3.6.Calsarcin 1(FATZ2,Myozenin2). Thecalsar cinshaveini-
tially been cloned via their ability to interact with the
protein phosphatase calcineurin, and they are localized to
the Z-disc [59]. Further research showed that calsarcin 1
knock-out animals do not have any spontaneous phenotype,
but, when subjected to biomechanical stress, for example,
TAC, they respond with increased calcineurin activity,
massive hypertrophy, and heart failure, which suggests
that calsarcin1 inhibits calcineurin function [60]. Recently
HCM-associated mutations have been identiﬁed in this
gene, making it another candidate gene for cardiomyopathy
[61].
3.7. Four-and-Half-Domain-LIM Proteins 1/2/3 (FHL1/2/3).
This group of proteins contains an amino-terminal zinc
ﬁnger/half LIM domain followed by four complete LIM
domains. This arrangement has led to the designation of this
c l a s so fp r o t e i n sa sf o u ra n dah a l fL I Md o m a i np r o t e i n s
(FHL). It encompasses currently ﬁve diﬀerent members, of
which FHL 1, 2, and 3 are expressed in striated muscle where
they localize to the sarcomeric Z-disc/I-band area. But they
can also sometimes be found in the nucleus [62]. FHL1
knock-out animals subjected to TAC which undergo pro-
tective remodelling—a favourable outcome. It has been sug-
gested that this protein plays an important role in the mech-
anism of pathologicalhypertrophy by sensing biomechanical
stress responses via theN2B titin stretch sensor domain. This
initiates changes in the titin- and MAPK-mediated responses
[63]. FHL1, 2, and 3 interact with extracellular-regulated
kinases(Erk),with, particularly, FHL2asan inhibitorofErk-
mediated transcriptional events [62].
Human mutations in FHL1 have been identiﬁed in pa-
tients aﬀected by X linked myopathy with postural mus-
cle atrophy (XMPMA, probably a form of Emery Drey-
fuss Muscular Dystrophy) [64] and scapuloperoneal (SP)
syndrome [65] as well as in patients with reducing body
myopathy (RBM). The latter is characterized by progressive
muscle weakness and the presence of cytoplasmic aggregates
(“aggresomes”) [66–68]. Aggresomes are inclusion bodies
formed when the cellular degradation machinery, usually
the ubiquitin proteasome system (UPS), is impaired or
overwhelmed. This leads to an accumulation of proteins
for disposal. The aggresomal response can be interpreted
as protective in the presence of a high load of damaged,
abnormal or misfolded protein within the cytoplasm which
fails to be degraded by the UPS and before autophagy
is fully engaged. A careful analysis of these aggregates in
RBM show that they contain a number of diﬀerent proteins,
such as desmin, ubiquitin, the lysosome-associated protein
LAMP1, and the endoplasmic reticulum chaperone GRP78
[68]. How mutations in FHL1 are precisely linked to these
aggresomes and may be to autophagy remains unclear, but
the presence of E3 ubiquitin ligases at the sarcomeric Z-disc
and the defects observed in this system in RBM link both
together.
3.8. Enigma/Enigma Homologue (ENH)/Cypher Family and
Actinin-Binding LIM Proteins (ALP). The enigma family of
proteinsconsistsofenigma,ENH,andcypher(mouse)(Zasp
(human isoform), Oracle) and is deﬁned by an amino-
terminal PDZ domain as well as by one to three carboxy-
terminal LIM domains [69]. All of them are expressed in
striated muscle and localize to the Z-disc, including enigma
[69], ENH [70], and cypher [71].
The ALP family consists of four proteins, namely, ALP
(PDLIM3),CLP36(CLIM1,Elﬁn,PDLIM1),RIL(PDLIM4),
and Mystique (SLIM, PDLIM2), which are all expressed
in the heart. Each member of this family contains an N-
terminal PDZ domain and a C-terminal LIM domain, and
actinin-associated LIM protein (ALP) is also present at the
Z-disc [72].
ENHand enigma [70]a n dc yp h e r[ 71]i n t e r a c twi t hp r o -
tein kinase C and inﬂuences this important pathway. In con-
trast, ALP is important for actin ﬁlament organization
[73]. Most of the genes in these two groups have been
knockedoutwithstrikingdiﬀerentphenotypes.Forexample,
the ALP knock-out mouse develops a pronounced right
ventricularcardiomyopathy, where a developmentalpathway
is responsible for this phenotype [72]. In this context, ENH-
deﬁcient animals have recently been generated and develop
aD C M - l i k ep h e n o t y p e[ 74]. Cypher is expressed in at
least six diﬀerent isoforms and plays an essential role in
striated muscle structure and function. Mice homozygous
nullforcypherdieduringtheﬁrstweekbecauseofcongenital
myopathy with symptoms that include decreased milk
intake, limb muscle weakness, cyanosis, and cardiomyopathy
[71].
Electron microscopy in these mice revealed severely dis-
organized skeletal and cardiac muscle with discontinuous/
punctuate Z-discs. These ﬁndings are somewhat more severe
but similar to defects found in MLP-deﬁcient mice [22, 75].
The fact that homozygous deletion of this gene in animals
leads to neonatal death implies that, although cypher is not
necessary for myoﬁbrillogenesis, it stabilizes Z-discs after the
organism starts to sustain its own cardiovascular system.
Conditional cypher knock-out animals support this conclu-
sion, where deletion of this gene in adult animals also leads
toaseverecardiomyopathyandheartfailurephenotype,with
Z-disc defects [76].
Knocking in two diﬀerent skeletal-muscle-speciﬁc iso-
forms to the cypher locus produces partial cardiac rescue,
with animals surviving up to one year [77]. In addition, hu-
man mutations have also been identiﬁed in the cypher
(ZASP) gene which produces dilated and or hypertrophic
cardiomyopathy, in left ventricular noncompaction [78–80].
Another set of human mutations has been found in patients
aﬀected by myoﬁbrillar myopathy (MFM), a disorder in
which disintegration of the Z-disc and then of the myoﬁbrils
is followed by abnormal accumulation of multiple proteins
such as desmin, αB crystalline, and dystrophin. Clinically
the disease is characterized by progressive muscle weakness,
often starting orinvolving distal muscles,butlimbgirdle and
scapuloperonealdistributionsmayalsooccur.Cardiomyopa-
thyandperipheralneuropathyarefrequentlypresent.Todate
all MFM-causing mutations are present in Z-disk proteins:6 Journal of Biomedicine and Biotechnology
Zasp, BAG3 (please see next chapter), desmin, αB crystalline,
myotilin, and ﬁlamin C [81].
The disease causing molecular mechanism for all of the
observed phenotypes, in the knock-out animals or in the
patients, is not well deﬁned. However, it is possible that
the D626N ZASP mutation, which changes the aﬃnity to
PKC, might cause the phenotype via alterations in this
pathway[78].Besideskeletalmuscleandcardiacphenotypes,
ZASP mutations also produce neuropathy, and; hence, the
spectrum of phenotypes caused by mutations in this gene
has been called zaspopathies [82]. (For an excellent review
on this topic, please see [83].)
3.9. Bcl2-Associated Athanogene (BAG3). Bcl2-associated
athanogene (BAG) family proteins belong to an evolutionary
conserved group of Hsp70/HSC70 binding cochaperones
with up to six diﬀerent members. They all contain a
conserved carboxy-terminal Hsp70/HSC70-binding domain
but diﬀer signiﬁcantly in their amino-terminal architecture,
which points to diﬀerent functions of diﬀerent family
members in cell biology. BAG3 is localized to the sarcomeric
Z-disc, and BAG3-deﬁcient animals are born in the expected
Mendelian ratios, undistinguishable from wild-type litter-
mates within the ﬁrst days after birth but develop, during
the ﬁrst and second weeks, severe skeletal and cardiac muscle
pathologies characterized by myoﬁbrillar degeneration and
apoptosis which leads to death at the age of 4 weeks [84].
In addition, human mutations in BAG3 have been found in
patientsaﬀectedbyMFM(pleasesee above)[85],andproba-
bly, most importantly, BAG3 recently has been identiﬁed as a
novel signiﬁcant candidate gene for human cardiomyopathy
andassociatedheart failureinlargegenome-wideassociation
studies (GWA) [86, 87].
3.10. Myotilin. Myotilin is a 57kDa cytoskeletal protein,
localized to the sarcomeric Z-disc and important for the
stabilityofthinﬁlaments duringmusclecontraction.Itbinds
F-actin, crosslinks actin ﬁlaments, and prevents latrunculin
A-induced ﬁlament disassembly. Mutations in this gene have
been associated with limb-girdle muscular dystrophy and
myoﬁbrillar myopathies (“myotilinopathies”). Von Nandel-
stadh and coworkers [88] analyzed the molecular mecha-
nisms underlying myotilinopathies and found at least two
diﬀerent calpain cleavage sites in myotilin and that the pro-
tein is degraded by the UPS. It turned out that proteolysis
inhibitor induced reduction in myotilin protein turnover,
which results in formation of intracellular myotilin and
actin-containing aggregates which are similar to the aggre-
gates observed in MFM. Moreover, myotilinopathy causing-
mutations prevent or at least signiﬁcantly slow down myo-
tilin protein degradation.
3.11. Alpha-B Crystalline and HSPB7. Alpha crystallins are
composed of two gene products: alpha-A and alpha-B (for
acidic and basic). Alpha crystallins can be induced by heat
shock and are members of the small heat shock protein
(sHSP or HSP20) family. They act as molecular chaperones,
but they do not renature proteins and release them in
the fashion of a true chaperone, instead they hold them
in large soluble aggregates, and posttranslational modiﬁ-
cations decrease their ability to chaperone. Two additional
functions of alpha crystallins are an autokinase activity and
participation in the intracellular architecture. Alpha-A and
alpha-B geneproductsare diﬀerentially expressed: alpha-A is
preferentially restricted to the lens, and alpha-B is expressed
widely in many tissues and organs and particularly in the
heart. Alpha-B crystallin interacts with desmin, vimentin,
and actin and is localized to the Z-disc [89, 90]. Moreover,
elevatedexpression ofalpha-Bcrystallin occursinmany neu-
rological diseases and a missense mutation cosegregated in
a family with a desmin-related myopathy [91]. Particularly,
the R120G alpha-B crystallin mutation has been analyzed in
great detail and increases autophagy in a transgenic mouse
model. Autophagy is likely to be an adaptive response to an
increase in misfolded proteins, and p62 promotes aggresome
formation and autophagy which protects cardiac myocytes
against proteotoxic stress [92].
HSPB7or cardiovascular heat shock protein (cvHSP)is a
170amino acidproteinwith highexpression inmyocardium.
The mRNA is induced in monocrotaline-induced right ven-
tricular hypertrophy but downregulated in left ventricular
hypertrophy following TAC. Moreover, the protein interacts
with alpha ﬁlamin and with actin-binding protein 280 [93]
and has been found to colocalize with alpha-B crystallin
[94]. However, recently a variety of diﬀerent GWAs pointed
to HSPB7 as an important novel candidate gene for DCM
[87, 95–97].
3.12. Desmin. Desmin, which is muscle-speciﬁc expressed,
belongs together with vimentin and lamin A/C to the inter-
mediate ﬁlaments (IF), a group of related proteins that share
commonstructuralandsequencefeatures,suchasthecentral
alpha helical rod and amino-terminal as well as carboxy-
terminal globulardomains. Desmin is amajor IFand present
in almost every cell type. In cardiac myocytes desmin con-
nects desmosomes not only with the Z-disc but also with
other organelles. Mutations in this gene cause a variety of
cardiac diseases (beside the above-discussed MFM). These
include desmin-related myopathy [98, 99], limb-girdle mus-
cular dystrophy [100]. They also cause several cardiomy-
opathies such as dilated cardiomyopathy (DCM) [101],
arrhythmogenic right-ventricular cardiomyopathy (ARVC)
[102],cardiomyopathy with advanced AVblockand arrhyth-
mia [103], familial restrictive cardiomyopathy [104], and
DCM with conduction system defects [105]. Desmin inter-
acts with a variety of proteins, and, because it is elastic, it can
sense deformation in a cellular structure. It has been linked
directly to mechanosensation [106]a n dm i g h tw e l lh a v ea
function via the “tensegration” of the intracellular cytoskele-
tal network; that is, its elasticity may cause a conformational
change in response to any type of mechanical stimulation.
3.13. Nebulin/Nebulette. Nebulinisa giant 600–900kDaﬁla-
mentousproteinpresentinskeletalmusclewhereasthemuch
shorter 100kDa-related nebulette is present in cardiac tissue.
Nebulin/nebulette run along actin ﬁlaments, and patientsJournal of Biomedicine and Biotechnology 7
with mutations in nebulin develop nemaline myopathy,
which is characterized by weakness, hypotonia, and de-
pressed or absent deep tendon reﬂexes. Interestingly two
diﬀerent nebulin knock-out mouse models recapitulate all
m a j o rf e a t u r e so ft h i sd i s e a s ea n da r ea v a i l a b l ef o rf u r t h e r
analysis [107, 108]. (Foran elegant recent review onnebulin,
please see [109].)
3.14. Phosphatases (Calcineurin/PPP3CA): Protein Kinases
(PKC). C a l c i n e u r i ni sah e t e r o d i m e ro fa5 8t o6 4k D ac a t -
alytic subunit, comprising calcineurin A and a 19kDa reg-
ulatory subunit, calcineurin B, and is well known to be one
of the major four Ser/Thr phosphatases found in eukaryotic
cells implicated in the control of cardiac hypertrophy as
well as associated heart failure [110]. Numerous articles
have pointed to the importance of this phosphatase, which
dephosphorylates nuclear factor activated T-cells (NFAT),
enablesnucleartranslocation ofthistranscription factor, and
initiates changes in gene expression, which in the majority
of cases leads to hypertrophy and associated heart failure.
Withinthe scopeofthispaperitis impossible to reviewcom-
pletely the importance of calcineurin; however, it colocalizes
with MLP at the sarcomeric Z-disc, and MLP is necessary for
calcineurin activation [21].
Protein kinase C (PKC) belongs to a large family of ser-
ine/threonine kinases with at least 12 diﬀerent members and
plays major roles in cardiac physiology in mediating hyper-
trophy and remodelling. They are classically subdivided into
threegroups:(i)classicalcalciumsensitive (
￿,β I,β II,γ),(ii)
novel isoforms which lack the calcium sensitive C2 domain
(
￿,
￿,
￿, θ), (iii) atypical isoforms (ζ, λ murine-ι in human)
which cannot be activated by calcium, diacylglycerol, or by
phorbol esters (reviewed in [111]). In particular, PKCε is
localizedtotheZ-disc[112]andittranslocatestothenucleus
uponbiomechanical stress (on TAC)[113],where thiskinase
most probably elicits a physiological type of hypertrophy
or at least exerts protective functions [114]. This view is
supported by transgenic over-expression of a constitutive
activePKCε inamouse modelwhere concentrichypertrophy
but not heart failure was observed [115].
In this context, protein kinase D (PKD) translocates to
the Z-disc in response to GPCR stimulation via norepineph-
rine, angiotensin II, and endothelin 1 and is activated via
forming acomplexwith PKCε—an eﬀectparticularly impor-
tantafterα adrenergic receptor triggered hypertrophy, where
PKCε-mediated PKD activation was essential [116]. This
type of hypertrophy might be antagonized by the MuRF1,
which is present at the sarcomeric Z-disc and which inhibits
PKCε [117].
3.15. Protein Degradation (Muscle Ring Fingers—MuRF):
Calpain. Protein degradations via the UPS and via diﬀerent
autophagy pathways are important processes in cardiac bi-
ology. The UPS recognizes speciﬁc proteins and places pol-
yubiquitinchains on them for subsequent destruction by the
proteasome.Thisprocessisimportant notonlyformisfolded
and damaged proteins, but also in regulating a variety of
diﬀerent cell signalling pathways involved in proliferation,
adaptation to stress, regulation of atrophy/hypertrophy-my-
ocardial remodelling, sarcopenia, and cell survival. However,
theUPSmayalso exert protectivefunctions duringischemia/
reperfusion or during myocardial remodelling. Some ubiq-
uitinated proteins aggregate and cannot be degraded via the
UPS, in which case cytosolic receptors such as p62, NBR,
and histone deacetylase 6 recognize aggregated ubiquitinated
proteins and target them for autophagy (for excellent recent
reviews, please see [118–120]). Here, because of limited
space, we just point out that E3 ubiquitin ligases MuRF1
and MuRF3 are localized to the sarcomeric Z-disc [121, 122]
in addition to atrogin 1, which mediates calcineurin degra-
dation and might also have major implications for cardiac
function [123]. Interestingly, MuRFs interact with serum
response factorandseemtoplayamajorroleintheinitiation
of myocardial hypertrophy [124], and particularly MuRF1
may have additional functions in muscle fatigue and twitch
potentiation [125].
In addition, calpain 1, which is an important protease
particularly for the selective degradation of cell cycle com-
ponents and for the regulation of apoptosis (together with
caspases) and forthecleavageofcellmembrane-cytoskeleton
components,has also beenshown to colocalizewith myotilin
at the sarcomeric Z-disc [126].
3.16. Transcription Factors and Mitogen-Activated Protein
Kinases (MAPK). The sarcomeric Z-disc harbours a number
of important transcription factors, such as NFAT, which is
a target of the phosphatase calcineurin and which has been
implicated in the onset of maladaptive myocardial hypertro-
phy. Another example is clock, a helix loop helix transcrip-
tion factor involvedin the circadian regulation of myocardial
function. The protein localizes to the Z-disc and increases its
expression as well as translocating into the nucleus upon an
increase in contractility. It also decreases its expression on
loss of contractility. It has been suggested that this protein
links glucose and fatty acid metabolism to myoﬁlament
crossbridge activity [127]. In addition, MLP, telethonin and,
FHL proteins shuttle into the nucleus, where they function
as cofactors of transcription [62, 128, 129]a n d / o ra ﬀect p53
[51].Ithas also becomeclearthatavariety of MAPKssuch as
Erk2 and p38 converge at the sarcomeric Z-disc/I-band area
and interact with FHL1 and 2 among others [62, 63, 130].
In conclusion, the sarcomeric Z-disc may well act as a
central structure linking myoﬁlament activity, mechanosen-
sation, mechanotransduction, and transcriptional activity,
an eﬀectwhich may be called Z-disc mechanotranscriptional
coupling.
4.Summary
The sarcomeric Z-disc, barely detectable in conventional
light microscopy, is a far more complex structure than ini-
tiallyrecognised. Novelprotein/proteininteractiondiscovery
strategies have led to the identiﬁcation of a variety of novel
Z-disc proteins which also led to the discovery of novel func-
tional aspects. The Z-disc is not only important for mechan-
ical stability and force transmission but also for signalling,8 Journal of Biomedicine and Biotechnology
mechanosensation, mechanotransduction, apoptosis, and
cell survival. The sarcomeric Z-disc might also be important
for protein turnover via the UPS and autophagy and has
molecular links to the t-tubular system as well as to the
sarcoplasmic reticulum. Links to energy turnover point to
additional important but less well-studied aspects. It is
important to stress that proteins localized at the sarcomeric
Z-disc might also be present at other locations such as
the nucleus, and, for a variety of diﬀerent Z-disc proteins,
nuclear shuttling has been demonstrated (for an excellent
review see: [131]). Mutations in Z-disc genes give rise to Z-
discopathies,a heterogenousgroupofdiseases encompassing
various cardiomyopathies such as DCM, HCM, ARVC,
titinopathies, zaspopathies, myotilinopathies, myoﬁbrillar
myopathy, and muscular dystrophies such as the LGMD
and XMPMA (please see table and ﬁgure). Next generation
sequencingisexpectedtosigniﬁcantly speedupthemutation
discovery process, and we can expect that within the next
few years a variety of novel mutations located in Z-disc
genes will be discovered. This will probably lead to the
identiﬁcation of novel and so far unknown Z-discopathies
andmayalsoleadtoabetterunderstandingoftheunderlying
molecular mechanism as well as to the development of novel
therapeutic strategies.
Moreover, most probably because of the numerous dif-
ferent functions carried by various genetic Z-disc protein
mutations, this could lead to perturbations in a vast array
of diﬀerent systems, and the sarcomeric Z-disc is becoming a
“hotspot” for cardiomyopathy-causing mutations [18].
ItispossibletodeﬁnecentralorcoreZ-discproteinssuch
as α actinin which serve probably primarily a mechanical
function. Another set of proteins may be called transversal
or partial Z-disc proteins such as titin, nebulin, or actin
which may serve a mechanical function as well but which
may have additional implications, for example, in signal
transduction, contractility, relaxation, and passive elasticity.
In addition, peripheral Z-disc proteins such as telethonin,
calsarcin, calcineurin, and MLP may be important for cell
signalling, communication, and survival. These proteins can
befoundatvariouslocationssuchasthenucleus,costameres,
intercalated discs, M-lines, I-bands, and the cytoplasm.
4.1. Future Directions. Future research needs to focus on
the link between the sarcomeric Z-disc (probably via MLP),
acetylation/deacetylation, and calcium sensitivity. To date a
clear genotype-phenotype relationship is not possible for
cardiomyopathy and heart-failure-causing mutations. More
eﬀorthastobeinvestedinanalyzingtherelationshipbetween
a mutation, its eﬀects on protein function (i.e., poison
peptide?), and its eﬀects on protein metabolism in general
(i.e., proteinopathy). The link between mechanosensation,
mechanotransduction, and apoptosis as well as autophagy
needs more investigation. In addition, telethonin might
link the sarcomeric Z-disc to the t-tubular system, to the
sarcoplasmic reticulum, and directly to apoptosis—these
links should be exploited for development of novel thera-
peutic strategies to combat heart failure, an otherwise lethal
condition.
The link between the sarcomeric Z-disc, gene expression,
and cell survival, which can be called Z-disc transcriptional
coupling, as well as the link between mechanical activity
andapoptosis(mechanoptosis)canprobablybeexploitedfor
novel therapeutic strategies [51].
Finally, Z-disc biologyisan exciting newly emerging ﬁeld
and will certainly provide important stimuli for biology and
physiology.
Abbreviations
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